AVMV
Avantis U.S. Mid Cap Value ETF
SMB
Adj. R2
0.854
Rel. Sharpe
1.619
Mkt beta
1.01
AUM
US$546M
MER
0.20%
Valuation
128
ETF comparison
Verified factor-similar pair
AVMV vs QVMM
These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.
SMB
Similarity score
84
Verified similar
The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.
Quick Read
- AVMV has the higher backtested relative Sharpe (1.619 vs 1.065).
- QVMM has the lower published fee (0.15% vs 0.20%).
- QVMM is cheaper on dividend valuation (120 vs 128, where 100 is each fund's historical median).
- QVMM has the stronger regression fit (adjusted R-squared 0.940 vs 0.854).
These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.
QVMM
Invesco S&P MidCap 400 QVM Multi-factor ETF
SMB
Adj. R2
0.940
Rel. Sharpe
1.065
Mkt beta
1.01
AUM
US$392M
MER
0.15%
Valuation
120
Factor Exposure Match
Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.
SMB
diff -0.08
HML
diff +0.08
RMW
diff +0.05
CMA
diff +0.15
UMD
diff +0.03
Why This Pair Matches
Exposure level
82
Exposure shape
98
Mkt beta diff
0.00
Rel. Sharpe diff
0.554
This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.
Monthly updates
Get the next US ETF leaders update
Get one monthly email when the US leaders table refreshes, plus methodology and comparison-page updates.
Monthly leaders refresh
Download-access updates
Low-volume research notes
One monthly email when the data drop lands. This browser will remember you after signup.